05:47 PM EST, 12/10/2024 (MT Newswires) -- Fady Ibraham Malik, Executive Vice President, Research & Development, on December 10, 2024, sold 7,300 shares in Cytokinetics ( CYTK ) for $369,639. Following the Form 4 filing with the SEC, Malik has control over a total of 116,071 shares of the company, with 116,071 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760224028977/xslF345X05/form4.xml